Chemico-Biological Interactions,
Journal Year:
2025,
Volume and Issue:
unknown, P. 111489 - 111489
Published: March 1, 2025
Oxidative
stress
and
chronic
inflammation
are
important
drivers
in
the
pathogenesis
progression
of
many
diseases,
such
as
cancers
breast,
kidney,
lung,
others,
autoimmune
diseases
(rheumatoid
arthritis),
cardiovascular
(hypertension,
atherosclerosis,
arrhythmia),
neurodegenerative
(Alzheimer's
disease,
Parkinson's
Huntington's
disease),
mental
disorders
(depression,
schizophrenia,
bipolar
disorder),
gastrointestinal
(inflammatory
bowel
colorectal
cancer),
other
disorders.
With
increasing
demand
for
less
toxic
more
tolerable
therapies,
flavonoids
have
potential
to
effectively
modulate
responsiveness
conventional
therapy
radiotherapy.
Flavonoids
polyphenolic
compounds
found
fruits,
vegetables,
grains,
plant-derived
beverages.
Six
twelve
structurally
different
flavonoid
subgroups
dietary
significance
include
anthocyanidins
(e.g.
pelargonidin,
cyanidin),
flavan-3-ols
epicatechin,
epigallocatechin),
flavonols
quercetin,
kaempferol),
flavones
luteolin,
baicalein),
flavanones
hesperetin,
naringenin),
isoflavones
(daidzein,
genistein).
The
health
benefits
related
their
structural
characteristics,
number
position
hydroxyl
groups
presence
C2=C3
double
bonds,
which
predetermine
ability
chelate
metal
ions,
terminate
ROS
radicals
formed
by
Fenton
reaction),
interact
with
biological
targets
trigger
a
response.
Based
on
these
can
exert
both
antioxidant
or
prooxidant
properties,
activity
ROS-scavenging
enzymes
expression
activation
proinflammatory
cytokines
(e.g.,
interleukin-1beta
(IL-1β),
interleukin-6
(IL-6),
tumor
necrosis
factor-alpha
(TNF-α)),
induce
apoptosis
autophagy,
target
key
signaling
pathways,
nuclear
factor
erythroid
2-related
2
(Nrf2)
Bcl-2
family
proteins.
This
review
aims
briefly
discuss
mutually
interconnected
aspects
oxidative
inflammatory
mechanisms,
lipid
peroxidation,
protein
oxidation,
DNA
damage,
mechanism
resolution
inflammation.
major
part
this
article
discusses
role
alleviating
inflammation,
two
common
components
human
diseases.
results
epidemiological
studies
also
presented.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Jan. 14, 2025
Childhood
obesity
poses
a
significant
public
health
challenge,
yet
the
molecular
intricacies
underlying
its
pathobiology
remain
elusive.
Leveraging
extensive
multi-omics
profiling
(methylome,
miRNome,
transcriptome,
proteins
and
metabolites)
rich
phenotypic
characterization
across
two
parts
of
Europe
within
population-based
Human
Early
Life
Exposome
project,
we
unravel
landscape
childhood
associated
metabolic
dysfunction.
Our
integrative
analysis
uncovers
three
clusters
children
defined
by
specific
profiles,
one
which
characterized
not
only
higher
adiposity
but
also
high
degree
complications.
This
high-risk
cluster
exhibits
complex
interplay
many
biological
pathways,
predominantly
underscored
inflammation-related
cascades.
Further,
incorporating
comprehensive
information
from
environmental
risk-scape
critical
pregnancy
period,
identify
pre-pregnancy
body
mass
index
pollutants
like
perfluorooctanoate
mercury
as
important
determinants
cluster.
Overall,
our
work
helps
to
potential
risk
factors
for
prevention
intervention
strategies
early
in
life
course
aimed
at
mitigating
long-term
consequences.
Obesity
encompasses
numerous
interconnected
pathological
mechanisms.
Here,
authors
show
that
integrating
data
distinct
profiles
prenatal
linked
dysfunction,
providing
insights
strategies.
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: May 9, 2024
Rheumatoid
arthritis
(RA)
is
a
chronic
systemic
autoimmune
disease
characterized
primarily
by
synovitis,
leading
to
the
destruction
of
articular
cartilage
and
bone
ultimately
resulting
in
joint
deformity,
loss
function,
significant
impact
on
patients’
quality
life.
Currently,
combination
anti-rheumatic
drugs,
hormonal
biologics
used
mitigate
progression.
However,
conventional
drug
therapy
has
limited
bioavailability,
long-term
use
often
leads
resistance
toxic
side
effects.
Therefore,
exploring
new
therapeutic
approaches
for
RA
great
clinical
importance.
Nanodrug
delivery
systems
offer
promising
solutions
overcome
limitations
drugs.
Among
them,
liposomes,
first
nanodrug
system
be
approved
application
still
widely
studied,
demonstrate
ability
enhance
efficacy
with
fewer
adverse
effects
through
passive
or
active
targeting
mechanisms.
In
this
review,
we
provide
review
research
progress
mechanisms
various
natural
biomimetic
nano-delivery
therapy.
Additionally,
predict
development
trends
prospects
these
systems,
offering
directions
precision
treatment
RA.
Molecular Biomedicine,
Journal Year:
2024,
Volume and Issue:
5(1)
Published: Oct. 17, 2024
Due
to
the
heterogeneous
nature
of
depression,
underlying
etiological
mechanisms
greatly
differ
among
individuals,
and
there
are
no
known
subtype-specific
biomarkers
serve
as
precise
targets
for
therapeutic
efficacy.
The
extensive
research
efforts
over
past
decades
have
not
yielded
much
success,
currently
used
first-line
conventional
antidepressants
still
ineffective
close
66%
patients.
Most
clinicians
use
trial-and-error
treatment
approaches,
which
seem
beneficial
only
a
fraction
patients,
with
some
eventually
developing
resistance.
Here,
we
review
evidence
from
both
preclinical
clinical
studies
on
pathogenesis
depression
antidepressant
response.
We
also
discuss
efficacy
pharmacological
non-pharmacological
well
novel
emerging
therapies.
reveals
that
in
response,
specific,
but
rather
involve
an
interplay
between
various
neurotransmitter
systems,
inflammatory
mediators,
stress,
HPA
axis
dysregulation,
genetics,
other
psycho-neurophysiological
factors.
None
current
hypotheses
sufficiently
accounts
interactional
involved
its
etiology
could
partly
explain
limited
success
discovering
efficacious
treatment.
Effective
management
treatment-resistant
(TRD)
requires
targeting
several
mechanisms,
using
and/or
personalized
modalities,
could,
example,
include
multi-target
pharmacotherapies
augmentation
psychotherapy
approaches.
Future
guided
by
interaction
provide
more
insights
into
potential
etiologies
TRD,
precision
biomarker
targets,
modalities.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(1), P. 133 - 133
Published: Jan. 20, 2025
Neuroinflammation
is
a
key
factor
in
the
progression
of
neurodegenerative
diseases,
driven
by
dysregulation
molecular
pathways
and
activation
brain’s
immune
system,
resulting
release
pro-inflammatory
oxidative
molecules.
This
chronic
inflammation
exacerbated
peripheral
leukocyte
infiltration
into
central
nervous
system.
Medicinal
plants,
with
their
historical
use
traditional
medicine,
have
emerged
as
promising
candidates
to
mitigate
neuroinflammation
offer
sustainable
alternative
for
addressing
conditions
green
healthcare
framework.
review
evaluates
effects
medicinal
plants
on
neuroinflammation,
emphasizing
mechanisms
action,
effective
dosages,
clinical
implications,
based
systematic
search
databases
such
PubMed,
SCOPUS,
Web
Science.
The
findings
highlight
that
like
Cleistocalyx
nervosum
var.
paniala,
Curcuma
longa,
Cannabis
sativa,
Dioscorea
nipponica
reduce
cytokines
(TNF-α,
IL-6,
IL-1β),
inhibit
enzymes
(COX-2
iNOS),
activate
antioxidant
pathways,
particularly
Nrf2.
NF-κB
primary
pathway
inhibited
across
studies.
While
anti-inflammatory
potential
these
significant,
variability
dosages
phytochemical
compositions
limits
translation.
Here,
we
are
modulators
underscoring
therapeutic
potential.
Future
research
should
focus
animal
models,
standardized
protocols,
safety
assessments,
integrating
advanced
methodologies,
genetic
studies
nanotechnology,
enhance
applicability
disease
management.
Molecular Biomedicine,
Journal Year:
2025,
Volume and Issue:
6(1)
Published: Feb. 5, 2025
Abstract
Sarcoidosis,
a
multisystemic
granulomatous
disease
with
unknown
etiology,
is
characterized
by
formation
of
noncaseating
granulomas,
which
can
affect
all
organs.
Recent
studies
have
made
outstanding
achievement
in
understanding
the
pathology,
genetics,
and
immune
dysregulation
involved
granuloma
sarcoidosis.
Antigen
stimulation
genetically
predisposed
individuals
enhances
phagocytic
activity
antigen-presenting
cells,
including
macrophages
dendritic
cells.
CD4
+
T
cells
initiate
dysregulated
responses
secrete
significant
quantities
inflammatory
cytokines,
interleukin
(IL)-2
interferon-gamma
(IFN-γ),
play
crucial
role
modulating
aggregation
fusion
to
form
granulomas.
The
current
therapeutic
strategies
focus
on
blocking
spread
granulomas
protect
organ
function
alleviate
symptoms.
efficacy
traditional
treatments,
such
as
glucocorticoids
immunosuppressants,
has
been
confirmed
management
Promising
agents
encompass
inhibitors
like
those
targeting
tumor
necrosis
factor
(TNF)-α,
well
signaling
pathways,
Janus
kinase
(JAK)
inhibitors,
exhibit
favorable
prospects
for
application.
Although
there
progress
identification
biomarkers
diagnosis,
prognosis,
severity
sarcoidosis,
specific
sensitive
yet
be
identified.
This
review
outlines
recent
advancements
molecular
mechanisms
Animals,
Journal Year:
2025,
Volume and Issue:
15(3), P. 444 - 444
Published: Feb. 6, 2025
This
literature
review
explores
the
impact
of
molecular,
genetic,
and
environmental
factors
on
efficacy
targeted
therapies
in
veterinary
medicine.
Relevant
studies
were
identified
through
systematic
searches
PubMed,
Web
Science,
Scopus,
ScienceDirect
using
keywords
such
as
“species-specific
treatment
strategies”,
“signalling
pathways”,
“epigenetic
paragenetic
influences”,
“targeted
therapies”,
“veterinary
medicine”,
“genetic
variation”,
“free
radicals
oxidative
stress”.
Inclusion
criteria
included
focusing
species-specific
therapeutic
responses,
genetic
influences,
stress.
To
ensure
that
only
most
recent
relevant
evidence
was
included,
peer-reviewed
publications
from
last
two
decades
considered.
Each
study
selected
for
analysis
critically
appraised,
with
a
particular
emphasis
methodological
quality,
experimental
design,
scientific
contribution
to
understanding
how
biological
influence
outcomes.
A
special
placed
used
comparative,
cross-species
approach
assess
variability
responses
potential
adverse
effects.
The
synthesises
role
epigenetic
highlights
importance
understand
By
highlighting
variation,
stress,
individual
species
differences,
argues
personalised
approaches.
emphasises
an
would
improve
care
inform
future
research
aimed
at
optimising
therapies,
ultimately
leading
better
animal
health
efficacy.
key
is
its
need
more
protocols
take
into
account
profiles
factors;
it
also
calls
greater
integration
studies.